Duphaston

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

dydrogesterone

Доступна с:

ABBOTT Biologicals B.V.

ИНН (Международная Имя):

dydrogesterone

дозировка:

10mg

Фармацевтическая форма:

tablets film-coated

Тип рецепта:

Prescription

Характеристики продукта

                                SUMMARY OF PRODUCT CHARACTERISTICS
Dydrogesterone
Abbott
Confidential information
1/10
This information is confidential
1.
NAME OF THE MEDICINAL PRODUCT
Duphaston 10 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 10 mg dydrogesterone.
Excipient(s) with known effect: Each tablet contains 111.1 mg Lactose
monohydrate.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
A round, biconvex, scored, white film-coated tablet, one side with
inscription ‘155’ on either side of
the score (size 7 mm).
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
PROGESTERONE DEFICIENCIES
• Treatment of dysmenorrhoea
• Treatment of endometriosis
• Treatment of secondary amenorrhoea
• Treatment of irregular cycles
• Treatment of dysfunctional uterine bleeding
• Treatment of pre-menstrual syndrome
• Treatment of threatened abortion
• Treatment of habitual abortion
• Treatment of infertility due to luteal insufficiency
HORMONE REPLACEMENT THERAPY
To counteract the effects of unopposed estrogen on the endometrium in
hormone replacement therapy
for women with disorders due to natural or surgical induced menopause
with an intact uterus.
SUMMARY OF PRODUCT CHARACTERISTICS
Dydrogesterone
Abbott
Confidential information
2/10
This information is confidential
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Dosages, treatment schedule and duration of treatment may be adapted
to the severity of the
dysfunction and the clinical response.
Dysmenorrhoea: 10 or 20mg mg dydrogesterone per day from day 5 to day
25 of the menstrual cycle.
Endometriosis: 10 to 30 mg dydrogesterone per day from day 5 to day 25
of the cycle or continuously.
Dysfunctional uterine bleeding: When treatment is started to arrest a
bleeding episode, 20 or 30 mg
dydrogesterone per day is to be given for up to 10 days
For continuous treatment, 10 or 20 mg dydrogesterone per day should be
give
                                
                                Прочитать полный документ
                                
                            

Документы на других языках

тонкая брошюра тонкая брошюра русский 05-06-2017

Поиск оповещений, связанных с этим продуктом

Просмотр истории документов